Lung cancer biomarker testing trial sees drop in deaths
By Liz Wells 10 January 2025
Biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths, new research reveals.
Medical Administrator (Stromness Surgery)
Band 3 (£26,869 - £28,998)
Orkney, Orkney IslandsBand 3 (£26,869 - £28,998)
Corporate Director Children and Young People’s Service
£136,853 to £159,178 plus relocation support
Northallerton, North Yorkshire£136,853 to £159,178 plus relocation support
Medical Administrator (Stromness Surgery)
Band 3 (£26,869 - £28,998)
Orkney, Orkney IslandsBand 3 (£26,869 - £28,998)
Corporate Director Children and Young People’s Service
£136,853 to £159,178 plus relocation support
Northallerton, North Yorkshire£136,853 to £159,178 plus relocation support
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
